Bathi sadurunge mbayar bunga, pajak, lan amortisasi: pfizer.com (PFE)

Logo grafis pfizer.com (PFE)

Pfizer Inc. (PFE) maintains high margins driven by efficient global logistics and cold chain management, as reflected in the company's EBITDA. The 23101.44 level captures the current operational resilience of a business supported by an extensive clinical trial network. However, declining vaccine demand and debt burdens create risks that the behemoth is mitigating through expansion into the oncology sector.

Pfizer Inc. (PFE) - Bathi operasional EBITDA saka 23.11.2025 nganti 10.11.2026

Pfizer (PFE) - rincian metrik lan laporan keuangan

- nilai pasar lan prakiraan target analis:
Rega bursa Pfizer Corp|PFE - Bagan rega target
- indikator kapitalisasi bursa perusahaan:
Nilai pasar Pfizer|PFE - Nilai Perusahaan
- rincian valuasi buku bisnis:
Ekuitas saben Saham Pfizer|PFE - Kapitalisasi Buku|Kapitalisasi Pasar marang Nilai Buku pfizer.com|PFE - Aset Agregat Perusahaan
- rincian struktur utang lan likuiditas bisnis:
Rasio Utang marang Ekuitas Pfizer Inc.|PFE - Utang jangka dawa marang modal|Tanggungan utang jangka cendhak marang ekuitas Pfizer Inc|PFE - Utang perusahaan|Rasio utang-utang marang kapitalisasi buku Pfizer|PFE - Utang jangka dawa perusahaan|Kewajiban jangka cendhak Pfizer|Koefisien jangkoan perantara pfizer.com
- indikator bathi lan kelipatan valuasi:
PFE - Penghasilan resik|Bathi forward Pfizer Inc.|PFE - Pangali P/E|Rasio prakiraan rega marang bathi pfizer.com|PFE - Rasio rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Pfizer|PFE - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajroning taun lumaku Pfizer|PFE - Bathi resik saben saham (EPS TTM)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan pfizer.com|PFE - Wutah bathi saben saham ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Pfizer Inc.
Analisis kabeh metrik perusahaan:Pfizer Corp, PFE
Barang unggulan Pfizer

Investors must assess the cash flow resilience of Pfizer Inc. (PFE) amid intense pressure from generics and R&D expenditures. An analysis of operational efficiency reveals whether the company possesses sufficient resources to acquire biotech startups. The EBITDA timeline demonstrates the actual cash inflow before taxes and depreciation, eliminating accounting distortions. This indicator measures the business's net ability to generate cash. The stability of this metric confirms the reliability of the asset's fundamental value.

Karo sapa Pfizer Inc. saingan

Eli Lilly and Co. (LLY) - Bathi sadurunge bunga, pajak, lan amortisasi|ABBV - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|AZN: Bathi sadurunge mbayar bunga, pajak, lan amortisasi|NVS: Bathi operasional EBITDA|Bathi operasional sadurunge amortisasi MRK|NVO (Novo Nordisk Inc.) - Bathi operasional EBITDA|Amgen Inc (AMGN) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Sanofi (SNY)|bms.com - Bathi operasional sadurunge amortisasi|Bathi operasional EBITDA GSK (GlaxoSmithKline)|Bathi operasional sadurunge potongan amortisasi Takeda Pharmaceutical Company|TEVA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi RDY|VTRS: Bathi operasional EBITDA|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi ROIV (roivant.com)|ZLAB (Zai Lab) - Bathi operasional EBITDA|Bausch Health Companies Inc. (BHC) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional sadurunge ngurangi amortisasi COSM (Cosmos Holdings)